Fortrea Launches AI-Powered Suite Of Solutions To Transform Clinical Trials

KUALA LUMPUR, April 8 (Bernama) -- Fortrea, a global clinical research organisation, has introduced Fortrea Intelligent Technology (FIT), a suite of innovative technology solutions designed to transform clinical trial operations.

FIT integrates persona-driven, artificial intelligence (AI)-powered solutions that automate workflows, streamline oversight and elevate productivity, enabling sponsors, investigator sites and project teams to deliver trials faster and with greater efficiency and quality.

According to Fortrea in a statement, the suite builds on existing offerings, including the Xcellerate platform, while introducing new solutions that connect processes across the clinical trial ecosystem.

It boasts applications for biopharma and biotech customers across clinical pharmacology, clinical development and medical device development, and can be deployed via full service, functional service or software-as-a-service (SaaS) models.

FIT is structured around three core pillars. The Lifecycle pillar focuses on accelerating trials from pre-award to final documentation through automation.

Meanwhile, Foresight leverages data analytics to deliver actionable insights, enabling faster decision-making and proactive risk management. Companion uses AI-driven, persona-based tools to enhance collaboration and productivity among study teams.

At the core of the suite is Xcellerate, Fortrea’s platform for risk-based quality management, central monitoring and oversight. Enhanced with AI and machine learning, it provides near-real-time insights, predictive analytics and automated workflows to reduce manual processes and improve trial execution.

Fortrea continues to expand the FIT portfolio, with additional solutions planned for future release.

-- BERNAMA